Assessing Immunogenicity Using Ex Vivo T cell Assays

Abstract

Assessing Immunogenicity Using Ex Vivo T cell Assays
This article discusses Antitope’s developed highly sensitive ex vivo T cell assay technology that can detect T cell responses against T cell epitopes in therapeutic proteins. These assays can be used to select non-immunogenic lead proteins as well as support the optimisation of leads by engineering out T cell epitopes. BioProcess International. November 2014

Interested in our services? Get In Touch